header image

On the Record

The following statements represent the Cephalon official corporate position on various topics of significance related to our company, products, or the industry.

Cephalon Response to March 18, 2009, JAMA Article "The Effects of Modafinil on Dopamine and Dopamine Transporters In the Male Human Brain"

Read the Cephalon response to findings outlined in the article, which are consistent with what we already know about PROVIGIL® (modafinil) Tablets [C-IV]. >>

Q&A on Settlements Regarding Investigations into Cephalon Business Practices

Browse questions and answers related to settlements and other steps Cephalon has taken to ensure we are able to continue to develop the medications patients and physicians have come to count on. >>

Please also browse our archive of past statements in the left navigation.